- Home
- IDN vs IKT Comparison
IDN vs IKT Comparison
Compare IDN & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDN
- IKT
- Stock Information
- Founded
- IDN 1994
- IKT 2008
- Country
- IDN United States
- IKT United States
- Employees
- IDN N/A
- IKT N/A
- Industry
- IDN Computer Software: Prepackaged Software
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- IDN Technology
- IKT Health Care
- Exchange
- IDN Nasdaq
- IKT Nasdaq
- Market Cap
- IDN 120.5M
- IKT 131.6M
- IPO Year
- IDN 1999
- IKT 2020
- Fundamental
- Price
- IDN $5.38
- IKT $1.66
- Analyst Decision
- IDN Strong Buy
- IKT Buy
- Analyst Count
- IDN 3
- IKT 2
- Target Price
- IDN $5.83
- IKT $8.00
- AVG Volume (30 Days)
- IDN 583.3K
- IKT 126.7K
- Earning Date
- IDN 08-07-2025
- IKT 08-13-2025
- Dividend Yield
- IDN N/A
- IKT N/A
- EPS Growth
- IDN N/A
- IKT N/A
- EPS
- IDN N/A
- IKT N/A
- Revenue
- IDN $20,211,000.00
- IKT N/A
- Revenue This Year
- IDN $9.35
- IKT N/A
- Revenue Next Year
- IDN $13.05
- IKT N/A
- P/E Ratio
- IDN N/A
- IKT N/A
- Revenue Growth
- IDN 4.55
- IKT N/A
- 52 Week Low
- IDN $1.92
- IKT $1.12
- 52 Week High
- IDN $6.49
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- IDN 60.65
- IKT 35.43
- Support Level
- IDN $5.08
- IKT $1.91
- Resistance Level
- IDN $5.63
- IKT $2.07
- Average True Range (ATR)
- IDN 0.45
- IKT 0.11
- MACD
- IDN -0.11
- IKT -0.03
- Stochastic Oscillator
- IDN 21.28
- IKT 0.00
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.